A Raggi1, M Leonardi1. 1. Neurology, Public Health and Disability Unit, Neurological Institute C. Besta IRCCS Foundation, Milan, Italy.
Abstract
OBJECTIVES: To address the relationship between years lived with a disability (YLDs), prevalence and cost of neurological diseases, and to test whether there is a European North-South gradient for national health expenditure, disability, costs and prevalence of neurological diseases. MATERIALS AND METHODS: Information on costs, prevalence and YLDs referred to 2010 were taken from the Study on the Cost of Disorders of the Brain and from the Global Burden of Disease study; data on health expenditure were taken from OECD reports. Selected conditions were as follows: brain tumours, stroke, dementia, Parkinson's disease, epilepsy, multiple sclerosis, migraine and tension-type headache; selected countries were from North (Denmark, Finland, Norway, Sweden) and South (Greece, Italy, Portugal, Spain) Europe. The association between the variables for each condition was tested using Spearman's correlation; Wilcoxon signed ranks test was used to test North-South Europe differences. RESULTS: Correlations were largely non-significant (except for stroke). YLDs and cost were generally lower in South-European countries, and prevalence was lower in North-European countries, but no significant differences were found. CONCLUSIONS: Health expenditure, YLDs, costs and prevalence of neurological conditions were generally not correlated across the eight countries. A clear North-South gradient was found for health expenditures, and partially for YLDs, costs and diseases' prevalence. We hypothesized that this is a consequence of the expansion of morbidity of neurological conditions connected to ageing, that health and welfare systems of selected countries were not prepared to face.
OBJECTIVES: To address the relationship between years lived with a disability (YLDs), prevalence and cost of neurological diseases, and to test whether there is a European North-South gradient for national health expenditure, disability, costs and prevalence of neurological diseases. MATERIALS AND METHODS: Information on costs, prevalence and YLDs referred to 2010 were taken from the Study on the Cost of Disorders of the Brain and from the Global Burden of Disease study; data on health expenditure were taken from OECD reports. Selected conditions were as follows: brain tumours, stroke, dementia, Parkinson's disease, epilepsy, multiple sclerosis, migraine and tension-type headache; selected countries were from North (Denmark, Finland, Norway, Sweden) and South (Greece, Italy, Portugal, Spain) Europe. The association between the variables for each condition was tested using Spearman's correlation; Wilcoxon signed ranks test was used to test North-South Europe differences. RESULTS: Correlations were largely non-significant (except for stroke). YLDs and cost were generally lower in South-European countries, and prevalence was lower in North-European countries, but no significant differences were found. CONCLUSIONS: Health expenditure, YLDs, costs and prevalence of neurological conditions were generally not correlated across the eight countries. A clear North-South gradient was found for health expenditures, and partially for YLDs, costs and diseases' prevalence. We hypothesized that this is a consequence of the expansion of morbidity of neurological conditions connected to ageing, that health and welfare systems of selected countries were not prepared to face.
Authors: Paulus Stefan Rommer; Frank Kamin; Mazen Abu-Mugheisib; Wolfgang Koehler; Frank Hoffmann; Alexander Winkelmann; Reiner Benecke; Uwe Klaus Zettl Journal: CNS Neurosci Ther Date: 2015-11-20 Impact factor: 5.243
Authors: Timothy J Steiner; Rigmor Jensen; Zaza Katsarava; Lars Jacob Stovner; Derya Uluduz; Latifa Adarmouch; Mohammed Al Jumah; Ali M Al Khathaami; Messoud Ashina; Mark Braschinsky; Susan Broner; Jon H Eliasson; Raquel Gil-Gouveia; Juan B Gómez-Galván; Larus S Gudmundsson; Akbar A Herekar; Nfwama Kawatu; Najib Kissani; Girish Baburao Kulkarni; Elena R Lebedeva; Matilde Leonardi; Mattias Linde; Otgonbayar Luvsannorov; Youssoufa Maiga; Ivan Milanov; Dimos D Mitsikostas; Teymur Musayev; Jes Olesen; Vera Osipova; Koen Paemeleire; Mario F P Peres; Guiovanna Quispe; Girish N Rao; Ajay Risal; Elena Ruiz de la Torre; Deanna Saylor; Mansoureh Togha; Sheng-Yuan Yu; Mehila Zebenigus; Yared Zenebe Zewde; Jasna Zidverc-Trajković; Michela Tinelli Journal: J Headache Pain Date: 2021-07-21 Impact factor: 7.277